Skip to main content

Table 1 (abstract A79). Comparison between the 2 study groups for outcomes investigated

From: Abstracts of the ICARE 2024 78th SIAARTI National Congress

 

Group A

Group B

p-value

Duration first stage

165 (120 – 278)

165 (90—285)

0,6632

(minutes; median [25p-75p])

Duration second stage

45 (30—65)

55 (27—88)

0,1736

(minutes; median [25p-75p])

Caesarean Sectiona

12 (24.0%)

8 (14.0%)

0,1132

Maximum oxytocin rate

1.14 (± 0.6)

0.91 (± 0.46)

0.066

(IU/h; mean [± ds])

Fetal heart rate abnormalitiesa

2 (4.0%)

10 (17.9%)

0.025

Episiotomya

21 (56.8%)

25 (52.1%)

0,4639

Blood loss > 500mla

23 (46%)

25 (43.9%)

0,2729

Peridural catether repositioninga

3 (6.0%)

0 (0.0%)

0.061

Rescue epidural top-upsa

3(6.0%)

1(1.8%)

0,1722

Apgar score at 1 minuteb

9 (9—9)

9 (8—9)

0.069

Apgar score at 5 minutesb

10 (9—10)

10 (9—10)

0,6097

Neonatal umbelical pHb

7.28 (7.23—7.33)

7.27 (7.25—7.33)

0,2722

Neonatal Intensive Care Rooma

5(10.0%)

4 (7.1%)

0,4153

  1. anumber/percentage
  2. bnumbers; median [25p-75p]